NCT01445262View on ClinicalTrials.gov

Drug Use Investigation for XYZAL®

CompletedOBSERVATIONAL

Enrollment

10,728

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Rhinitis, Allergic, Perennial and Seasonal

Interventions

DRUG

Levocetirizine

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01445262 - Drug Use Investigation for XYZAL® | Biotech Hunter | Biotech Hunter